Atlas Trials

Efficacy of Targeted And Response-Guided Albumin Therapy Versus Standard Medical Treatment In Outcomes Of Recurrent Ascites In Patients With Decompensated Cirrhosis.

Clinical trial NCT04679571 · UNKNOWN

Trial details

NCT number
NCT04679571
Sponsor
Institute of Liver and Biliary Sciences, India
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Decompensated Cirrhosis
Start date
2020-12-30
Primary completion
2022-09-30
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.